Fremtidig kontraception – forskning og kliniske muligheder
- 1.
Morell V. Evolution of sex: a new look at monogamy. Science 1998: 281; 1982 – 3.
- 2.
World Health Organisation. Life in the 21st century a vision for all. I: The world health report. Geneva: WHO, 1998: 120.
- 3.
Baird DT. Potential contraceptive effects of antigestogens. I: Donaldson M, Dorflinger L, Brown SS, Benet LZ, eds. Clinical applications of mifepristone (RU 486) and other antiprogestins. Washington DC: National Academy Press, 1993: 148 – 83.
- 4.
Gemzell-Danielsson K, Swahn M-L, Svalander P, Bygdeman M. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation. Hum Reprod 1993; 8: 870 – 3.
- 5.
McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 1995; 9: 659 – 69.
- 6.
Martin CW. Cross cultural acceptability of hormonal male contraception. Acta Obstet Gynecol Scand 1997; 167 (suppl 76): P72.62.
- 7.
Feng H, Sandlow JI, Sparks AE, Sandra A. Development of an immunocontraceptive vaccine. Current status. J Reprod Med 1999, 44: 759 – 65.
- 8.
Byskov AG, Baltsen M, Andersen CY. Meiosis-activating sterols: background, discovery, and possible use. J Mol Med 1998; 76: 818 – 23.
- 9.
Lessey BA. The use of integrins for the assessment of uterine receptivity. Fertil Steril 1994; 61: 812 – 4.
- 10.
Luukkainen T, Toivonen J. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties Contraception 1995; 52: 269 – 76.
- 11.
Bentin-Ley U, Sjogren A, Nilsson L, Hamberger L, Larsen JF, Horn T. Presence of uterine pinopodes at the embryo-endometrial interface during human implantation in vitro. Hum Reprod 1999; 14: 515 – 20.
- 12.
Bentin-Ley U, Lindenberg S, Horn T, Larsen JF. Ultrastructure of endometrial epithelial cells in a three-dimensional cell culture system for human implantation studies. J Assist Reprod Genet 1995; 12: 632 – 8.
- 13.
Ho PC. Emergency contraception: methods and efficacy. Curr Opin Obstet Gynecol 2000; 12: 175 – 9.
- 14.
Ellertson C, Shochet T, Blanchard K, Trussell J. Emergency contraception: a review of the programmatic and social science literature. Contraception 2000; 61: 145 – 86.
- 15.
World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation. Menstrual regulation by mifepristone plus prostaglandin: results from a multicentre trial. Hum Reprod 1995; 10: 308 – 14.
- 16.
World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation. Special Programme of Research, Development and Research Training. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. BJOG 2000; 107: 524 – 30.
- 17.
D’Cruz OJ. Uckun FM. Novel derivatives of phenethyl-5-bromopyridylthiourea and dihydroalkoxybenzyloxopyrimidine are dual-function spermicides with potent anti-human immunodeficiency virus activity. Biol Reprod 1999; 60: 1419 – 2.
- 18.
Cook RL, Rosenberg MJ. Do spermicides containing nonoxynol-9 prevent sexually transmitted infections? Sex Transm Dis 1998; 25: 144 – 50.